Observational Recruiting
NCT05188612 on ClinicalTrials.gov
International Survey of Acute Coronavirus Syndromes-COVID-19
Official title: International Survey of Acute Coronavirus Syndromes (ISACS)-COVID-19
- Sponsor: University of Bologna
- Collaborators: Associazione Per La Ricerca Cardiologica (Roma)
- Enrollment: 10000 (Estimated)
- Study start: 2021-12-01 (Actual)
- Primary completion: 2026-12-31 (Estimated)
- Study completion: 2026-12-31 (Estimated)
- Allocation: N/a
- InterventionModel: N/a
- Masking: None
- PrimaryPurpose: Other
Brief Summary
In response to the COVID-19 crisis, ISACS-TC has promoted a new registry of the existing and further centers of the same geographic areas to support clinical research to prevent, and treat the COVID-19 illness. These efforts are made possible by the generous contributions of clinical research volunteers in some of the countries participating to the prior acute coronary syndrome network.
Conditions
- COVID-19
Intervention / Treatment
- Combination Product: Observational (registry)
Primary Outcome Measures
-
Death all cause
(30-day)
Occurrence of all cause death -
Death all cause
(6 month)
Occurrence of all cause death -
Death all cause
(12-month)
Occurrence of all cause death
Countries
Italy, Spain
Locations and Investigators
-
University of Bologna, Bologna, Italy (Recruiting)
- Olivia Manfrini
- IR-Hospital de la Santa Creu i Sant Pau, UAB, Barcelona, Spain (Recruiting)
Study Officials
- Olivia Manfrini, MD (Study Director) — University of Bologna
- Lina Badimon, PhD (Study Director) — IR-Hospital de la Santa Creu i Sant Pau, UAB, Barcelona